Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof

Details for Australian Patent Application No. 2004260657 (hide)

Owner Boehringer Ingelheim Vetmedica, Inc.

Inventors Kroll, Jeremy J.; Roof, Michael B; Knittel, Jeffrey P.

Agent Davies Collison Cave

Pub. Number AU-B-2004260657

PCT Pub. Number WO2005/011731

Priority 60/490,001 25.07.03 US

Filing date 15 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 7 June 2012

International Classifications

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/011731 Priority application(s): WO2005/011731

7 June 2012 Application Accepted

  Published as AU-B-2004260657

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260662-Reduced trans fat product

2004260656-Regulation of mammalian keratinous tissue using N-acyl amino acid compositons